Read More Pharma Industry News Sanofi Consumer Healthcare India Q1 FY2025 results: PAT climbs 12.9% post-demerger, stock holds premium valuation Sanofi Consumer Healthcare India Q1 FY2025 PAT rose 12.9% to ₹500 million. Read stock analysis, investor sentiment, and growth outlook post demerger. byPallavi MadhirajuMay 4, 2025